Clinical Trial: Cell Therapy in Limb Girdle Muscular Dystrophy
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Intrathecal Autologous Mononuclear Cell Therapy for Limb Girdle Muscular Dystrophy
Brief Summary: The purpose of this study was to study the effect of stem cell therapy on Limb Girdle Muscular Dystrophy patients.
Detailed Summary:
Sponsor: Neurogen Brain and Spine Institute
Current Primary Outcome: Change in Functional Independence Measure (FIM) scale [ Time Frame: 1 year ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Change in Manual Muscle Testing (MMT) [ Time Frame: 1 year ]
Original Secondary Outcome: Same as current
Information By: Neurogen Brain and Spine Institute
Dates:
Date Received: September 12, 2014
Date Started: December 2010
Date Completion:
Last Updated: September 23, 2016
Last Verified: September 2016